Merck Group
默克
Merck Group appears in elsewhere's corpus primarily as a multinational pharmaceutical company that has been both a collaborator and an acquisition target in China's healthcare sector. Triastek, a Chinese 3D-printed drug startup backed by Yunqi Capital, named Merck among its global pharma partners alongside Eli Lilly and Boehringer Ingelheim as of 2023-2024 . Separately, Chinese buyout firm CBC Group acquired Merck's cardiovascular business as part of a series of deals in 2023-2024 that expanded its revenue from roughly 600 million yuan to over 2 billion yuan, as CBC founder Fu Wei described to 暗涌Waves . The bundle does not distinguish whether these references point to the German Merck KGaA or the US-based Merck & Co. (MSD), nor does it cover Merck's broader corporate profile or history.
AI-generated — may contain errors, please verify.
Coverage
Fu Wei, who spent ten years doing control buyouts, said they are the blue-collar workers of the investment industry.
Go with the flow.
暗涌Waves·Over $1.2 Billion in Total Value: Triastek Announces First-Ever Technology Platform International Collaboration in Chinese Pharmaceutical History with BioNTech | Yunqi Capital
Empowering Digital Transformation in Pharmaceutical Development
云启资本·"Triastek" Closes 150 Million Yuan Pre-C Round to Accelerate Commercialization of 3D-Printed Drugs | Yunqi Capital
Pioneering a New Era of Intelligent Drug Discovery
云启资本·How Can a "3D Printer" Boost Productivity in the Pharmaceutical Industry? | The B-Side of Entrepreneurship
Take the hard, meaningful path
云启资本·
